Similar articles

• EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis.

  Feng H, Lopez GY, Kim CK, Alvarez A, Duncan CG, Nishikawa R, Nagane M, Su AJ, Auron PE, Hedberg ML, Wang L, Raizer JJ, Kessler JA, Parsa AT, Gao WQ, Kim SH, Minata M, Nakano I, Grandis JR, McLendon RE, Bigner DD, Lin HK, Furnari FB, Cavenee WK, Hu B, Yan H, Cheng SY. Feng H, et al. J Clin Invest. 2014 Sep;124(9):3741-56. doi: 10.1172/JCI73093. Epub 2014 Jul 25. J Clin Invest. 2014. Retraction in: J Clin Invest. 2025 May 15;135(10):e194718. doi: 10.1172/JCI194718. PMID: 25061874 Free PMC article. Retracted.
• Dynamic multi-site phosphorylation by Fyn and Abl drives the interaction between CRKL and the novel scaffolding receptors DCBLD1 and DCBLD2.

  Schmoker AM, Weinert JL, Kellett KJ, Johnson HE, Joy RM, Weir ME, Ebert AM, Ballif BA. Schmoker AM, et al. Biochem J. 2017 Nov 21;474(23):3963-3984. doi: 10.1042/BCJ20170615. Biochem J. 2017. PMID: 29025973 Free PMC article.
• DCBLD2 deletion increases hyperglycemia and induces vascular remodeling by inhibiting insulin receptor recycling in endothelial cells.

  Guo L, Zong Y, Yang W, Lin Y, Feng Q, Yu C, Liu X, Li C, Zhang W, Wang R, Li L, Pei Y, Wang H, Liu D, Niu H, Nie L. Guo L, et al. FEBS J. 2024 Sep;291(18):4076-4095. doi: 10.1111/febs.17198. Epub 2024 Jun 14. FEBS J. 2024. PMID: 38872483
• Tumor necrosis factor receptor-associated factor 6 contributes to malignant behavior of human cancers through promoting AKT ubiquitination and phosphorylation.

  Shi J, Liu Z, Xu Q. Shi J, et al. Cancer Sci. 2019 Jun;110(6):1909-1920. doi: 10.1111/cas.14012. Epub 2019 Apr 29. Cancer Sci. 2019. PMID: 30945383 Free PMC article.
• The relationship between TRAF6 and tumors.

  Li J, Liu N, Tang L, Yan B, Chen X, Zhang J, Peng C. Li J, et al. Cancer Cell Int. 2020 Sep 3;20:429. doi: 10.1186/s12935-020-01517-z. eCollection 2020. Cancer Cell Int. 2020. PMID: 32905356 Free PMC article. Review.